Cogent Biosciences, Inc.
COGT
$39.16
$0.180.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.38% | 12.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.28% | 0.87% | |||
| Operating Income | -10.28% | -0.87% | |||
| Income Before Tax | -10.07% | -2.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.07% | -2.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.07% | -2.14% | |||
| EBIT | -10.28% | -0.87% | |||
| EBITDA | -10.39% | -0.85% | |||
| EPS Basic | 8.40% | -1.10% | |||
| Normalized Basic EPS | 8.40% | -1.11% | |||
| EPS Diluted | 8.40% | -1.10% | |||
| Normalized Diluted EPS | 8.40% | -1.11% | |||
| Average Basic Shares Outstanding | 20.15% | 1.02% | |||
| Average Diluted Shares Outstanding | 20.15% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||